0000905718-20-000595.txt : 20200618 0000905718-20-000595.hdr.sgml : 20200618 20200618160902 ACCESSION NUMBER: 0000905718-20-000595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200616 FILED AS OF DATE: 20200618 DATE AS OF CHANGE: 20200618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EMSTER KURT VON CENTRAL INDEX KEY: 0001252524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 20972570 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD STREET 2: SUITE 350 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 vaxcyte_fm4jun1620.xml X0306 4 2020-06-16 0 0001649094 Vaxcyte, Inc. PCVX 0001252524 EMSTER KURT VON C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404 1 0 0 0 Common Stock, $0.001 par value per share 2020-06-16 4 C 0 2185415 A 2185415 I See Footnotes Common Stock, $0.001 par value per share 2020-06-16 4 C 0 1217074 A 3402489 I See Footnotes Common Stock, $0.001 par value per share 2020-06-16 4 C 0 454812 A 3857301 I See Footnotes Common Stock, $0.001 par value per share 2020-06-16 4 C 0 298917 A 4156218 I See Footnotes Common Stock, $0.001 par value per share 2020-06-16 4 P 0 12500 16.00 A 4168718 I See Footnotes Series A Preferred Stock 2020-06-16 4 C 0 2185415 0 D Common Stock, $0.001 par value per share 2185415 0 I See Footnotes Series B Preferred Stock 2020-06-16 4 C 0 1217074 0 D Common Stock, $0.001 par value per share 1217074 0 I See Footnotes Series C Preferred Stock 2020-06-16 4 C 0 454812 0 D Common Stock, $0.001 par value per share 454812 0 I See Footnotes Series D Preferred Stock 2020-06-16 4 C 0 298917 0 D Common Stock, $0.001 par value per share 298917 0 I See Footnotes Shares are held by ABV VI. Abingworth LLP is the investment manager of ABV VI and has been delegated with all investment and dispositive power over the securities held by ABV VI. Reporting Person is a member of the investment committee of Abingworth LLP, which approves investment and voting decisions by a majority vote, and no individual member has the sole control or voting power over the shares held by ABV VI. From time to time, the investment committee may delegate investment and voting authority over certain securities held by ABV VI to employees of Abingworth subject to the supervision and oversight of the investment committee, including any limits on such authority imposed by the investment committee in its discretion and the right of the investment committee to revoke such authority at any time. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any. Each share of Series A, Series B, Series C and Series D Preferred Stock was convertible into shares of Common Stock, $0.001 par value per share ("Common Stock") on a one-for-one basis with no expiration date and automatically converted into Common Stock upon the closing of the initial public offering. /s/ John Heard, as attorney-in-fact 2020-06-18